🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Status
Not Yet Recruiting
Location
Beijing Hospital
Start Date
2025-09-30
Trial ID
NCT07156500
Treatments Being Tested
This is a multicenter, randomized, open-label, parallel clinical study to e...
Status
Recruiting
Location
The Affiliated Hospital of Qingdao University
Start Date
2025-04-16
Trial ID
NCT07057674
Treatments Being Tested
The main purpose of this study is to assess the Efficacy and safety of HS-2...
Status
Completed
Location
Peking University People's Hospital
Start Date
2024-11-16
Trial ID
NCT06839664
Treatments Being Tested
This is a 32-week, phase 2, randomized study, HS-20094 and placebo were dou...
Status
Completed
Location
Tianjin Medical University General Hospital (Zhu Xianyi Memorial Hospital)
Start Date
2024-02-06
Trial ID
NCT06901648
Treatments Being Tested
This study will test olatorepatide (study drug) to determine how safe and e...
Status
Active Not Recruiting
Location
Diablo Clinical Research - Flourish Research
Start Date
2026-03-16
Trial ID
NCT07431086
Treatments Being Tested
The study is being conducted to evaluate the efficacy and safety of HS-2009...
Status
Not Yet Recruiting
Location
Shandong Provincial Hospital
Start Date
2025-09-30
Trial ID
NCT07156539
Treatments Being Tested
This is a study of HS-20094 in participants with overweight and obesity. Th...
Status
Completed
Location
the Fourth Affiliated Hospital of Harbin Medical University
Start Date
2023-10-16
Trial ID
NCT06118021
This study includes two parts (Single Ascending Dose, SAD; Multiple-Ascendi...
Status
Unknown
Location
Beijing University First Hospital
Start Date
2021-11-01
Trial ID
NCT05116410
This is a randomized, placebo and active-control, multiple-dose, phase IIa ...
Status
Completed
Location
Peking University First Hospital
Start Date
2023-05-31
Trial ID
NCT06118008
Treatments Being Tested
This study will test an experimental drug called olatorepatide ("study drug...
Status
Recruiting
Location
Diablo Clinical Research - Flourish Research
Start Date
2026-07-28
Trial ID
NCT07685808
Treatments Being Tested